201 related articles for article (PubMed ID: 21952235)
1. Sirt1 is a regulator of bone mass and a repressor of Sost encoding for sclerostin, a bone formation inhibitor.
Cohen-Kfir E; Artsi H; Levin A; Abramowitz E; Bajayo A; Gurt I; Zhong L; D'Urso A; Toiber D; Mostoslavsky R; Dresner-Pollak R
Endocrinology; 2011 Dec; 152(12):4514-24. PubMed ID: 21952235
[TBL] [Abstract][Full Text] [Related]
2. The Sirtuin1 activator SRT3025 down-regulates sclerostin and rescues ovariectomy-induced bone loss and biomechanical deterioration in female mice.
Artsi H; Cohen-Kfir E; Gurt I; Shahar R; Bajayo A; Kalish N; Bellido TM; Gabet Y; Dresner-Pollak R
Endocrinology; 2014 Sep; 155(9):3508-15. PubMed ID: 24949665
[TBL] [Abstract][Full Text] [Related]
3. Low sirtuin 1 levels in human osteoarthritis subchondral osteoblasts lead to abnormal sclerostin expression which decreases Wnt/β-catenin activity.
Abed É; Couchourel D; Delalandre A; Duval N; Pelletier JP; Martel-Pelletier J; Lajeunesse D
Bone; 2014 Feb; 59():28-36. PubMed ID: 24184155
[TBL] [Abstract][Full Text] [Related]
4. SOST Gene Inhibits Osteogenesis from Adipose-Derived Mesenchymal Stem Cells by Inducing Th17 Cell Differentiation.
You L; Chen L; Pan L; Peng Y; Chen J
Cell Physiol Biochem; 2018; 48(3):1030-1040. PubMed ID: 30041240
[TBL] [Abstract][Full Text] [Related]
5. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength.
Li X; Ominsky MS; Niu QT; Sun N; Daugherty B; D'Agostin D; Kurahara C; Gao Y; Cao J; Gong J; Asuncion F; Barrero M; Warmington K; Dwyer D; Stolina M; Morony S; Sarosi I; Kostenuik PJ; Lacey DL; Simonet WS; Ke HZ; Paszty C
J Bone Miner Res; 2008 Jun; 23(6):860-9. PubMed ID: 18269310
[TBL] [Abstract][Full Text] [Related]
6. SOST is a target gene for PTH in bone.
Keller H; Kneissel M
Bone; 2005 Aug; 37(2):148-58. PubMed ID: 15946907
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Sirt1 in mesenchymal stem cells protects against bone loss in mice by FOXO3a deacetylation and oxidative stress inhibition.
Sun W; Qiao W; Zhou B; Hu Z; Yan Q; Wu J; Wang R; Zhang Q; Miao D
Metabolism; 2018 Nov; 88():61-71. PubMed ID: 30318050
[TBL] [Abstract][Full Text] [Related]
8. Advanced oxidation protein products aggravate age‑related bone loss by increasing sclerostin expression in osteocytes via ROS‑dependent downregulation of Sirt1.
Zeng J; Xiao Q; Li X; Chen J
Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33907818
[TBL] [Abstract][Full Text] [Related]
9. Reversing LRP5-dependent osteoporosis and SOST deficiency-induced sclerosing bone disorders by altering WNT signaling activity.
Chang MK; Kramer I; Keller H; Gooi JH; Collett C; Jenkins D; Ettenberg SA; Cong F; Halleux C; Kneissel M
J Bone Miner Res; 2014 Jan; 29(1):29-42. PubMed ID: 23901037
[TBL] [Abstract][Full Text] [Related]
10. Spaciotemporal association and bone morphogenetic protein regulation of sclerostin and osterix expression during embryonic osteogenesis.
Ohyama Y; Nifuji A; Maeda Y; Amagasa T; Noda M
Endocrinology; 2004 Oct; 145(10):4685-92. PubMed ID: 15217980
[TBL] [Abstract][Full Text] [Related]
11. Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis.
Li X; Ominsky MS; Warmington KS; Morony S; Gong J; Cao J; Gao Y; Shalhoub V; Tipton B; Haldankar R; Chen Q; Winters A; Boone T; Geng Z; Niu QT; Ke HZ; Kostenuik PJ; Simonet WS; Lacey DL; Paszty C
J Bone Miner Res; 2009 Apr; 24(4):578-88. PubMed ID: 19049336
[TBL] [Abstract][Full Text] [Related]
12. Sirt1 is involved in decreased bone formation in aged apolipoprotein E-deficient mice.
Hong W; Xu XY; Qiu ZH; Gao JJ; Wei ZY; Zhen L; Zhang XL; Ye ZB
Acta Pharmacol Sin; 2015 Dec; 36(12):1487-96. PubMed ID: 26592520
[TBL] [Abstract][Full Text] [Related]
13. Human serine protease HTRA1 positively regulates osteogenesis of human bone marrow-derived mesenchymal stem cells and mineralization of differentiating bone-forming cells through the modulation of extracellular matrix protein.
Tiaden AN; Breiden M; Mirsaidi A; Weber FA; Bahrenberg G; Glanz S; Cinelli P; Ehrmann M; Richards PJ
Stem Cells; 2012 Oct; 30(10):2271-82. PubMed ID: 22865667
[TBL] [Abstract][Full Text] [Related]
14. Sirtuin 1 deficiency decreases bone mass and increases bone marrow adiposity in a mouse model of chronic energy deficiency.
Louvet L; Leterme D; Delplace S; Miellot F; Marchandise P; Gauthier V; Hardouin P; Chauveau C; Ghali Mhenni O
Bone; 2020 Jul; 136():115361. PubMed ID: 32289519
[TBL] [Abstract][Full Text] [Related]
15. Regulation of sclerostin by the SIRT1 stabilization pathway in osteocytes.
Kim JM; Yang YS; Xie J; Lee O; Kim J; Hong J; Boldyreff B; Filhol O; Chun H; Greenblatt MB; Gao G; Shim JH
Cell Death Differ; 2022 Aug; 29(8):1625-1638. PubMed ID: 35169297
[TBL] [Abstract][Full Text] [Related]
16. SIRT1, a promising regulator of bone homeostasis.
Chen Y; Zhou F; Liu H; Li J; Che H; Shen J; Luo E
Life Sci; 2021 Mar; 269():119041. PubMed ID: 33453243
[TBL] [Abstract][Full Text] [Related]
17. The role of sirtuin 1 in osteoblastic differentiation in human periodontal ligament cells.
Lee YM; Shin SI; Shin KS; Lee YR; Park BH; Kim EC
J Periodontal Res; 2011 Dec; 46(6):712-21. PubMed ID: 21745208
[TBL] [Abstract][Full Text] [Related]
18. Nicotinamide phosphoribosyltransferase (Nampt) affects the lineage fate determination of mesenchymal stem cells: a possible cause for reduced osteogenesis and increased adipogenesis in older individuals.
Li Y; He X; Li Y; He J; Anderstam B; Andersson G; Lindgren U
J Bone Miner Res; 2011 Nov; 26(11):2656-64. PubMed ID: 21812028
[TBL] [Abstract][Full Text] [Related]
19. Sost deficiency led to a greater cortical bone formation response to mechanical loading and altered gene expression.
Pflanz D; Birkhold AI; Albiol L; Thiele T; Julien C; Seliger A; Thomson E; Kramer I; Kneissel M; Duda GN; Kornak U; Checa S; Willie BM
Sci Rep; 2017 Aug; 7(1):9435. PubMed ID: 28842678
[TBL] [Abstract][Full Text] [Related]
20. Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells.
Bäckesjö CM; Li Y; Lindgren U; Haldosén LA
J Bone Miner Res; 2006 Jul; 21(7):993-1002. PubMed ID: 16813520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
